# LanzaTech Global, Inc.: overview LNZA · Nasdaq · CIK 1843724 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lnza.md) · [Financials](/companies/lnza/financials.md) · [Filings](/companies/lnza/filings.md) · [Insiders](/companies/lnza/insiders.md) Latest reported revenue: [$9.0m](/filings/0001628280-26-056933.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-056933). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.9](/filings/0001628280-25-053255.md) | [12.0 d](/filings/0001628280-26-022505.md) | [9.5](/filings/0001628280-26-034773.md) | [9.1](/filings/0001628280-26-056933.md) | [9.3](/filings/0001628280-25-053255.md) | [28.0 d](/filings/0001628280-26-022505.md) | [12.0](/filings/0001628280-26-034773.md) | [9.0](/filings/0001628280-26-056933.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(331.5%)](/filings/0001628280-25-053255.md) | [(224.6%) d](/filings/0001628280-26-022505.md) | [(327.5%)](/filings/0001628280-26-034773.md) | [(354.9%)](/filings/0001628280-26-056933.md) | [(168.7%)](/filings/0001628280-25-053255.md) | [(0.7%) d](/filings/0001628280-26-022505.md) | [(81.6%)](/filings/0001628280-26-034773.md) | [(109.5%)](/filings/0001628280-26-056933.md) | | Net margin | % | [(577.6%)](/filings/0001628280-25-053255.md) | [(224.4%) d](/filings/0001628280-26-022505.md) | [(202.8%)](/filings/0001628280-26-056933.md) | [(357.8%)](/filings/0001628280-26-056933.md) | [30.8%](/filings/0001628280-25-053255.md) | [(0.3%) d](/filings/0001628280-26-022505.md) | [(122.1%)](/filings/0001628280-26-056933.md) | [2044.7%](/filings/0001628280-26-056933.md) | | Diluted EPS | $ per share | [(29.04)](/filings/0001628280-25-053255.md) | not reported | [(9.79)](/filings/0001628280-26-034773.md) | [(14.90)](/filings/0001628280-26-056933.md) | [0.99](/filings/0001628280-25-053255.md) | not reported | [(1.77)](/filings/0001628280-26-034773.md) | [15.81](/filings/0001628280-26-056933.md) | | Free cash flow | $m | [(26.7) d](/filings/0001628280-25-053255.md) | [(21.4) d](/filings/0001628280-26-022505.md) | [(21.8)](/filings/0001628280-26-034773.md) | [(21.9) d](/filings/0001628280-26-056933.md) | [(16.0) d](/filings/0001628280-25-053255.md) | [(6.4) d](/filings/0001628280-26-022505.md) | [(9.3)](/filings/0001628280-26-034773.md) | [(2.1) d](/filings/0001628280-26-056933.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | [37.3](/filings/0001628280-24-008069.md) | [62.6](/filings/0001628280-25-017874.md) | [49.6](/filings/0001628280-26-022505.md) | [55.8](/filings/0001628280-26-022505.md) | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | [(202.4%)](/filings/0001628280-24-008069.md) | [(169.9%)](/filings/0001628280-25-017874.md) | [(219.7%)](/filings/0001628280-26-022505.md) | [(141.7%)](/filings/0001628280-26-022505.md) | | Net margin | % | [(204.5%)](/filings/0001628280-24-008069.md) | [(214.1%)](/filings/0001628280-25-017874.md) | [(277.7%)](/filings/0001628280-26-022505.md) | [(87.7%)](/filings/0001628280-26-022505.md) | | Diluted EPS | $ per share | [(12.37)](/filings/0001628280-24-008069.md) | [(0.79)](/filings/0001628280-25-017874.md) | [(69.71)](/filings/0001628280-26-022505.md) | [(22.27)](/filings/0001628280-26-022505.md) | | Free cash flow | $m | [(95.4)](/filings/0001628280-24-008069.md) | [(106)](/filings/0001628280-25-017874.md) | [(94.4)](/filings/0001628280-26-022505.md) | [(66.1)](/filings/0001628280-26-022505.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lnza/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [HIGHBRIDGE CAPITAL MANAGEMENT LLC](/funds/919185.md) | 2026-06-30 | $3.1m | 458,904 | | New +458,904 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.1m | 453,019 | | Added +370,546 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.7m | 255,164 | | Added +244,442 | | [Polar Asset Management Partners Inc.](/funds/1326389.md) | 2026-06-30 | $1.7m | 247,945 | | New +247,945 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.3m | 194,460 | | New +194,460 | | [NOVO HOLDINGS A/S](/funds/1388325.md) | 2026-06-30 | $1.1m | 158,148 | | Unchanged | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $677.5k | 42,320 | | New +42,320 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $672.7k | 98,612 | | Added +53,780 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $355.5k | 52,131 | | New +52,131 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $222.3k | 32,602 | | Added +22,100 | ## Recent filings [All 389 filings](/companies/lnza/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-20 | 21:06 ET | [8-K](/filings/0001628280-26-066526.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events | 0001628280-26-066526 | | 2026-08-14 | 11:58 ET | [10-Q](/filings/0001628280-26-056933.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056933 | | 2026-08-14 | 11:51 ET | [8-K](/filings/0001628280-26-056930.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056930 | | 2026-06-24 | 20:07 ET | [8-K](/filings/0001628280-26-045168.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-045168 | | 2026-06-04 | 12:05 ET | [8-K](/filings/0001628280-26-040616.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-040616 | | 2026-05-18 | 11:05 ET | [8-K](/filings/0001628280-26-035797.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-035797 | | 2026-05-14 | 10:09 ET | [10-Q](/filings/0001628280-26-034773.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034773 | | 2026-05-14 | 10:02 ET | [8-K](/filings/0001628280-26-034770.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034770 | | 2026-05-04 | 20:32 ET | [8-K](/filings/0001628280-26-029858.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-029858 | | 2026-04-29 | 19:44 ET | [DEF 14A](/filings/0001539497-26-001238.md) | Proxy statement, period 2026-04-29 | 0001539497-26-001238 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-022505.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6b2efc79-93be-4dea-9f84-0206691e164f) ## About the filer - CIK: 1843724 - Tickers: LNZA, LNZAW - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.